PTGS2 and non-small cell lung carcinoma: Correlation and agreement were poor between urinary PGE2 metabolite and COX-2 staining by immunohistochemistry, and prognosis in NSCLC with elevated urinary PGE metabolite was improved by celecoxib treatment [7].